News Sentiment

ASBP sentiment intelligence

Aspire BioPharma, Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 45 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 6.24 Week of 17 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

79/100 classification confidence.

Company focus 36

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

+3.8% over one week, -5.2% over four weeks, trend inactive, and below fair value.

Latest direct headline Negative

Aspire Bi clarifies public warrant terms after two reverse stock splits; exercise price now $13,800

Market Reaction

Balanced read

61/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 79/100 classification
One-week reaction 3.8% Price confirming higher
Trend fit Trend inactive -5.2% over four weeks
Fair value -99.9% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 9
Neutral 33
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 36
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Market source 11
TradingView 9
ACCESS Newswire 3
TradingKey 3
Stock Titan 2
Investing.com 2
simplywall.st 2
Treasure Coast News 1

Event Lens

What the news is about

Classified themes
Market update 23
Earnings 15
Deals and strategy 3
Regulatory and legal 2
Capital return 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-45 of 45